A61K 51/0472
Containing heavy metals
Official title: {containing heavy metals, e.g. hemin, hematin, melarsoprol}
A61K51/0472 (Containing heavy metals) appears on 23 US grants and 45 published applications in this corpus.
Search patents in A61K- Granted patents
- 23
- Published applications
- 45
- Assignees
- 27
- Inventors
- 73
- Latest grant
- 1 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 1 | 2 |
| 2013 | 2 | 3 |
| 2014 | 1 | 6 |
| 2015 | 4 | 4 |
| 2016 | 1 | 4 |
| 2017 | 3 | 1 |
| 2018 | 2 | 4 |
| 2019 | 0 | 0 |
| 2020 | 0 | 4 |
| 2021 | 2 | 1 |
| 2022 | 1 | 4 |
| 2023 | 1 | 1 |
| 2024 | 2 | 4 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Radiolabeling and formulation for scale up of 64Cu-DOTATATE1 Oct 2024US 12,102,696 B2Curium US LLC
- PSMA targeted fluorescent agents for image guided surgery20 Aug 2024US 12,065,413 B2The Johns Hopkins Universty
- PSMA-targeting compounds and uses thereof30 May 2023US 11,661,402 B2The Johns Hopkins University
- Preparation of metal-pyridine derivative complexes for use in medical imaging15 Nov 2022US 11,498,936 B2University of Northumbria at Newcastle
- PSMA targeted fluorescent agents for image guided surgery1 Jun 2021US 11,021,450 B2The Johns Hopkins University
- Zwitterionic metal chelators20 Aug 2026US 2026/0241044 A1Curadel Surgical Innovations, Inc.
- Radiotracers and therapeutics binding to fibroblast activation protein (fap)5 Dec 2024US 2024/0399001 A1Blue Earth Diagnostics Limited
- Radiolabeling and formulation for scale up of 64cu-dotatate24 Oct 2024US 2024/0350679 A1Curium US LLC
- Loading of human car t-cells with superparamagnetic iron-based particles for magnetic targeting11 Jul 2024US 2024/0226346 A2Friedrich-Alexander-Universität Erlangen-Nürnberg
- Loading of human car t-cells with superparamagnetic iron-based particles for magnetic targeting25 Jan 2024US 2024/0024521 A1Friedrich-Alexander-Universität Erlangen-Nürnberg
Most cited
By later US patents
- PSMA-targeting compounds and uses thereof47US 9,056,841 B2The Johns Hopkins University · 2015
- Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents46US 9,044,468 B2The Johns Hopkins University · 2015
- Cobalamin conjugates useful as imaging and therapeutic agents31US 6,838,073 B1Mayo Foundation for Medical Education and Research · 2005
- Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents16US 9,694,091 B2The Johns Hopkins University · 2017
- PSMA-targeting compounds and uses thereof12US 9,776,977 B2The Johns Hopkins University · 2017